Company intelligence / Profile preview

Seeker Biologics

Boston, Massachusetts, United Statesnveloptx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Seeker Biologics was a Boston-based biotech company focused on developing novel biologic therapies for autoimmune, allergic, and other inflammatory diseases. Despite raising $24.1 million in funding and being backed by 5AM Ventures with experienced leadership from ex–Translate Bio executives, the company ceased operations in April 2023 after failing to achieve its scientific objectives. No clinical results were reported as the pipeline did not reach human trials

Therapeutic areas: Immunology
Modalities: Biologics (focus on protein-based therapeutics)
Industry: Biotech

Partnerships

Backed by venture capital firm 5AM Ventures

Beyond the preview

Go deeper on Seeker Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seeker Biologics.

Explore the full profile